Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
ESOMEPRAZOLE SIVEM PHARMACEUTICALS ULC Actual shortage 40MG Updated Report 2022-01-17 108844
ESOMEPRAZOLE SIVEM PHARMACEUTICALS ULC Actual shortage 40MG Updated Report 2022-01-17 108841
ESOMEPRAZOLE SIVEM PHARMACEUTICALS ULC Actual shortage 40MG Updated Report 2022-01-17 107747
ESOMEPRAZOLE SIVEM PHARMACEUTICALS ULC Actual shortage 20MG Updated Report 2022-01-17 119343
DILANTIN-125 SUSPENSION UPJOHN CANADA ULC Actual shortage 125MG Updated Report 2022-01-17 151037
VIACORAM SERVIER CANADA INC Actual shortage 10MG 14MG New Report 2022-01-17 152922
OPTIMYXIN EURO-PHARM INTERNATIONAL CANADA INC Actual shortage 0.025MG 10000UNIT Updated Report 2022-01-17 124877
LIORESAL INTRATHECAL 2MG/ML NOVARTIS PHARMACEUTICALS CANADA INC Resolved 2MG Updated Report 2022-01-17 148460
LIORESAL INTRATHECAL 0.5MG/ML NOVARTIS PHARMACEUTICALS CANADA INC Resolved 0.5MG Updated Report 2022-01-17 148466
FOLIC ACID INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 5MG Updated Report 2022-01-17 152914
DEXTROSE 5% INJECTION FRESENIUS KABI CANADA LTD Actual shortage 50MG Updated Report 2022-01-17 150956
HEPARIN SODIUM INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 1000UNIT Updated Report 2022-01-17 148577
HEPARIN SODIUM INJECTION, USP FRESENIUS KABI CANADA LTD Resolved 10000UNIT Updated Report 2022-01-17 150947
HYDROMORPHONE HYDROCHLORIDE INJECTION, USP FRESENIUS KABI CANADA LTD Resolved 2MG Updated Report 2022-01-17 150232
NAT-QUETIAPINE NATCO PHARMA (CANADA) INC Actual shortage 100MG Updated Report 2022-01-17 81900
NAT-QUETIAPINE NATCO PHARMA (CANADA) INC Actual shortage 200MG Updated Report 2022-01-17 81903
NAT-QUETIAPINE NATCO PHARMA (CANADA) INC Actual shortage 300MG Updated Report 2022-01-17 81906
NAT-LEVETIRACETAM NATCO PHARMA (CANADA) INC Actual shortage 250MG Updated Report 2022-01-17 75810
NAT-QUETIAPINE NATCO PHARMA (CANADA) INC Actual shortage 25MG Updated Report 2022-01-17 65944
PMS-BUPRENORPHINE-NALOXONE PHARMASCIENCE INC Resolved 8MG 2MG Updated Report 2022-01-17 95445
TOLOXIN PENDOPHARM DIVISION OF PHARMASCIENCE INC Resolved 0.05MG Updated Report 2022-01-17 149657
NAT-ERLOTINIB NATCO PHARMA (CANADA) INC Actual shortage 150MG Updated Report 2022-01-17 129553
NAT-ERLOTINIB NATCO PHARMA (CANADA) INC Actual shortage 25MG Updated Report 2022-01-17 129536
NAT-ERLOTINIB NATCO PHARMA (CANADA) INC Actual shortage 100MG Updated Report 2022-01-17 129550
ZENHALE ORGANON CANADA INC. Actual shortage 5MCG 200MCG Updated Report 2022-01-17 152458
STERILE LIGHT MINERAL OIL 100% OMEGA LABORATORIES LIMITED Anticipated shortage 100% New Report 2022-01-17 152870
PMS-RABEPRAZOLE EC PHARMASCIENCE INC Actual shortage 10MG Updated Report 2022-01-17 149260
PMS-LOSARTAN-HCTZ PHARMASCIENCE INC Actual shortage 25MG 100MG Updated Report 2022-01-17 149230
CORTROSYN INJ 0.25MG AMPHASTAR PHARMACEUTICALS, INC. Actual shortage 0.25MG Updated Report 2022-01-17 147831
VIACORAM SERVIER CANADA INC Resolved 10MG 14MG Updated Report 2022-01-16 151621
PRADAXA BOEHRINGER INGELHEIM (CANADA) LTD LTEE Actual shortage 150MG Updated Report 2022-01-16 152835
OXY.IR PURDUE PHARMA Actual shortage 10MG Updated Report 2022-01-15 152782
ACH-EZETIMIBE ACCORD HEALTHCARE INC Actual shortage 10MG Updated Report 2022-01-15 152785
ACH-BICALUTAMIDE ACCORD HEALTHCARE INC Actual shortage 50MG Updated Report 2022-01-15 152788
GABAPENTIN CAPSULES USP ACCORD HEALTHCARE INC Actual shortage 300MG Updated Report 2022-01-15 152792
GABAPENTIN CAPSULES USP ACCORD HEALTHCARE INC Actual shortage 100MG Updated Report 2022-01-15 152800
ACH-TEMOZOLOMIDE ACCORD HEALTHCARE INC Actual shortage 5MG Updated Report 2022-01-15 152821
ACH-TEMOZOLOMIDE ACCORD HEALTHCARE INC Actual shortage 5MG Updated Report 2022-01-15 152824
HEPARIN SODIUM 20000UNITS IN 5% DEXTROSE INJ B. BRAUN MEDICAL INC Resolved 5G 4000UNIT Updated Report 2022-01-14 148890
!!T3 LEVOFLOXACIN IN 5% DEXTROSE INJECTION PFIZER CANADA ULC Actual shortage 5MG Updated Report 2022-01-14 147653
!!T3 LEVOFLOXACIN IN 5% DEXTROSE INJECTION PFIZER CANADA ULC Actual shortage 5MG Updated Report 2022-01-14 147650
!T3 LEVOFLOXACIN IN 5% DEXTROSE INJECTION PFIZER CANADA ULC Anticipated shortage 5MG Updated Report 2022-01-14 148580
CEQUA SUN PHARMA GLOBAL FZE Actual shortage 0.09% Updated Report 2022-01-14 149218
!!T3 APRESOLINE STERIMAX INC Actual shortage 20MG Updated Report 2022-01-14 91935
INQOVI OTSUKA PHARMACEUTICAL CO LTD Anticipated shortage 100MG 35MG Updated Report 2022-01-14 152829
FOQUEST ELVIUM LIFE SCIENCES Actual shortage 85MG Updated Report 2022-01-14 151794
CARDIOLITE LANTHEUS MI CANADA INC Actual shortage 1MG Updated Report 2022-01-14 142747
APO-OLMESARTAN APOTEX INC Actual shortage 20MG Updated Report 2022-01-14 152324
APO-METHYLPHENIDATE ER APOTEX INC Actual shortage 54MG Updated Report 2022-01-14 150181
APO-GABAPENTIN APOTEX INC Actual shortage 300MG Updated Report 2022-01-14 152310

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
FLUOROURACIL INJECTION USP PFIZER CANADA ULC Discontinued 50MG Updated Report 2022-01-17 125282
ZYVOXAM 600 MG PFIZER CANADA ULC Discontinued 600MG Updated Report 2022-01-17 103480
PMS-CILAZAPRIL PHARMASCIENCE INC To be discontinued 1.0MG Updated Report 2022-01-17 110517
TRANSDERM-NITRO 0.6 NOVARTIS PHARMACEUTICALS CANADA INC Discontinued 0.6MG Updated Report 2022-01-17 138767
DEXTROSE INJECTION USP ICU MEDICAL CANADA INC Discontinued 100MG Updated Report 2022-01-17 141414
STERILE WATER FOR INJECTION USP ICU MEDICAL CANADA INC Discontinued 100% Updated Report 2022-01-14 152657
!!T3 PROPYL-THYRACIL PALADIN LABS INC. Discontinued 50MG Updated Report 2022-01-13 101076
!!T3 PROPYL-THYRACIL PALADIN LABS INC. Discontinued 100MG Updated Report 2022-01-13 107174
!!T3 ERWINASE JAZZ PHARMACEUTICALS FRANCE SAS Discontinued 10000UNIT Updated Report 2022-01-13 129623
STERILE WATER FOR INJECTION USP ICU MEDICAL CANADA INC To be discontinued 100% New Report 2022-01-12 152615